Admedus is a structural heart company delivering
clinically superior solutions to help healthcare professionals to
create life-changing outcomes for patients.

Our Technology

Our proprietary ADAPT engineering process
produces implantable tissue bio-scaffolds for a range of cardiovascular and vascular applications.


Clinically superior solutions that last a lifetime


Positive Data on CardioCel® Published In Leading Journal
A link to purchase a copy of the manuscript can be found here
Read more.
Annual General Meeting
Our CEO Wayne Paterson presenting on the vision for Admedus at this years Annual General Meeting in Brisbane, Australia. To...
Read more.

Exciting News out of the Baylor College of Medicine - The Children's Hospital of San Antonio. Dr. Daniel Nento impl…
#HeartValveDisease is a treatable disease, but if left unchecked it can cause death within two years when diagnosed…
This week is #HeartValveWeek19 in Europe. Did you know, 30% of people over 65 in Europe don’t know anything about…
CardioCel benefits patients with different anatomies for intracardiac application.
CARDIOCEL®3D APPROVED FOR SALE IN ISRAEL. “We are pleased to offer surgeons and patients in Israel access to our Ca…